Natixis Advisors, L.P. Becton Dickinson & CO Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Natixis Advisors, L.P. holds 236,682 shares of BDX stock, worth $53.4 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

236,682

Previous 76,609 208.95%

Holding current value

$53.4 Million

Previous $17.9 Million 218.72%

% of portfolio

0.11%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$221.47 - $242.41 $35.5 Million - $38.8 Million	160,073 Added 208.95%	236,682 $57.1 Million
Q2 2024 Aug 01, 2024	BUY	$225.07 - $246.17 $1 Million - $1.09 Million	4,446 Added 6.16%	76,609 $17.9 Million
Q1 2024 Apr 25, 2024	BUY	$233.45 - $247.73 $1.5 Million - $1.59 Million	6,436 Added 9.79%	72,163 $17.9 Million
Q4 2023 Feb 06, 2024	SELL	$232.24 - $267.23 $5.81 Million - $6.69 Million	-25,020 Reduced 27.57%	65,727 $16 Million
Q3 2023 Nov 13, 2023	BUY	$254.9 - $283.59 $3.86 Million - $4.3 Million	15,148 Added 20.04%	90,747 $23.5 Million
Q2 2023 Aug 15, 2023	BUY	$238.39 - $265.32 $1.36 Million - $1.51 Million	5,703 Added 8.16%	75,599 $20 Million
Q1 2023 May 11, 2023	SELL	$229.71 - $259.35 $704,979 - $795,945	-3,069 Reduced 4.21%	69,896 $17.3 Million
Q4 2022 Jan 27, 2023	SELL	$218.29 - $256.91 $688,268 - $810,037	-3,153 Reduced 4.14%	72,965 $18.6 Million
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $29,342 - $151,932	-575 Reduced 0.75%	76,118 $17 Million
Q2 2022 Aug 12, 2022	SELL	$234.74 - $275.42 $622,061 - $729,863	-2,650 Reduced 3.34%	76,693 $18.9 Million
Q1 2022 May 12, 2022	BUY	$243.64 - $270.48 $9.87 Million - $11 Million	40,528 Added 104.41%	79,343 $20.6 Million
Q4 2021 Feb 08, 2022	BUY	$230.08 - $250.94 $585,093 - $638,140	2,543 Added 7.01%	38,815 $9.76 Million
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $2.18 Million - $2.4 Million	-9,371 Reduced 20.53%	36,272 $8.92 Million
Q2 2021 Aug 12, 2021	SELL	$232.65 - $254.58 $124,002 - $135,691	-533 Reduced 1.15%	45,643 $11.1 Million
Q1 2021 May 05, 2021	BUY	$232.09 - $256.88 $18,799 - $20,807	81 Added 0.18%	46,176 $11.2 Million
Q4 2020 Feb 12, 2021	BUY	$221.92 - $245.94 $1.24 Million - $1.37 Million	5,579 Added 13.77%	46,095 $11.5 Million
Q3 2020 Nov 12, 2020	SELL	$215.77 - $276.76 $540,288 - $693,007	-2,504 Reduced 5.82%	40,516 $9.43 Million
Q2 2020 Aug 11, 2020	SELL	$219.9 - $263.41 $426,606 - $511,015	-1,940 Reduced 4.31%	43,020 $10.3 Million
Q1 2020 Apr 27, 2020	BUY	$195.69 - $279.01 $2.68 Million - $3.83 Million	13,715 Added 43.9%	44,960 $10.3 Million
Q4 2019 Feb 10, 2020	SELL	$236.45 - $266.82 $20,571 - $23,213	-87 Reduced 0.28%	31,245 $8.5 Million
Q3 2019 Nov 12, 2019	BUY	$230.58 - $256.08 $717,795 - $797,177	3,113 Added 11.03%	31,332 $7.93 Million
Q2 2019 Aug 12, 2019	BUY	$217.4 - $246.08 $1.62 Million - $1.84 Million	7,461 Added 35.94%	28,219 $7.11 Million
Q1 2019 May 15, 2019	BUY	$206.05 - $248.17 $348,224 - $419,407	1,690 Added 8.86%	20,758 $5.18 Million
Q4 2018 Feb 13, 2019	BUY	$204.73 - $257.93 $399,428 - $503,221	1,951 Added 11.4%	19,068 $4.3 Million
Q3 2018 Nov 13, 2018	BUY	$233.07 - $256.0 $237,964 - $261,376	1,021 Added 6.34%	17,117 $4.47 Million
Q2 2018 Aug 14, 2018	BUY	$208.1 - $233.85 $340,243 - $382,344	1,635 Added 11.31%	16,096 $0
Q1 2018 May 10, 2018	BUY	$205.46 - $240.27 $236,073 - $276,070	1,149 Added 8.63%	14,461 $3.13 Million
Q4 2017 Feb 14, 2018	SELL	$189.0 - $222.64 $1.37 Million - $1.61 Million	-7,230 Reduced 35.2%	13,312 $2.85 Million
Q3 2017 Nov 14, 2017	BUY	$186.89 - $198.9 $3.84 Million - $4.09 Million	20,542	20,542 $4.03 Million

Others Institutions Holding BDX

# of Institutions

1,739

Shares Held

251M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.4B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Becton Dickinson & CO Transaction History